Paper15840409
Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice.
Li H and 5 others. Eur J Pharmacol, 2005. Cited by 71 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice. Papers, record 15840409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15840409
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromatin | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Triterpenes | Major topic |
| Analysis of Variance | |
| Animals | |
| Autoantibodies | |
| Cell Proliferation | |
| Female | |
| Immunoassay | |
| Immunoglobulin G | |
| Interferon-gamma | |
| Interleukin-10 | |
| Kidney Glomerulus | |
| Lymphocytes | |
| Mice | |
| Mice, Inbred BALB C | |
| Nitric Oxide | |
| Pentacyclic Triterpenes | |
| Proteinuria | |
| Spleen |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38471722 | Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice. | Lupus Sci Med | 2024 | https://conductscience.org/library/papers/38471722 | PubMed |
| 38203539 | Withaferin A and Celastrol Overwhelm Proteostasis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203539 | PubMed |
| 36817139 | Celastrol inhibits store operated calcium entry and suppresses psoriasis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36817139 | PubMed |
| 36760253 | Effects and mechanisms of Celastrol on the formation of neutrophil extracellular traps (NETs). | Ann Transl Med | 2023 | https://conductscience.org/library/papers/36760253 | PubMed |
| 35845629 | Overexpression of TwSQS, TwSE, and TwOSC Regulates Celastrol Accumulation in Cambial Meristematic Cells and Dedifferentiated Cells. | Front Plant Sci | 2022 | https://conductscience.org/library/papers/35845629 | PubMed |
| 34193168 | Celastrol inhibits the proliferation and angiogenesis of high glucose-induced human retinal endothelial cells. | Biomed Eng Online | 2021 | https://conductscience.org/library/papers/34193168 | PubMed |
| 32954678 | Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32954678 | PubMed |
| 32335899 | Heat shock protein 90 inhibition and multi-target approach to maximize cardioprotection in ischaemic injury. | Br J Pharmacol | 2020 | https://conductscience.org/library/papers/32335899 | PubMed |
| 30569150 | Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAIL‑induced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/30569150 | PubMed |
| 30093945 | Celastrol aggravates LPS-induced inflammation and injuries of liver and kidney in mice. | Am J Transl Res | 2018 | https://conductscience.org/library/papers/30093945 | PubMed |
| 29435447 | Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis. | Front Med (Lausanne) | 2017 | https://conductscience.org/library/papers/29435447 | PubMed |
| 29069290 | Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation. | Carcinogenesis | 2018 | https://conductscience.org/library/papers/29069290 | PubMed |
| 29025894 | Nascent RNA sequencing reveals a dynamic global transcriptional response at genes and enhancers to the natural medicinal compound celastrol. | Genome Res | 2017 | https://conductscience.org/library/papers/29025894 | PubMed |
| 28664158 | Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases. | Front Med (Lausanne) | 2017 | https://conductscience.org/library/papers/28664158 | PubMed |
| 28303228 | Molecular cloning and functional identification of a cDNA encoding 4-hydroxy-3-methylbut-2-enyl diphosphate reductase from Tripterygium wilfordii. | Acta Pharm Sin B | 2017 | https://conductscience.org/library/papers/28303228 | PubMed |
| 28154736 | Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology. | World J Stem Cells | 2017 | https://conductscience.org/library/papers/28154736 | PubMed |
| 27671821 | Celastrol and Its Role in Controlling Chronic Diseases. | Adv Exp Med Biol | 2016 | https://conductscience.org/library/papers/27671821 | PubMed |
| 27405485 | Control of autoimmune inflammation by celastrol, a natural triterpenoid. | Pathog Dis | 2016 | https://conductscience.org/library/papers/27405485 | PubMed |
| 25866772 | Effect of celastrol on growth inhibition of prostate cancer cells through the regulation of hERG channel in vitro. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25866772 | PubMed |
| 25611379 | Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. | Cell Death Dis | 2015 | https://conductscience.org/library/papers/25611379 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15840409
GET https://conductscience.org/api/papers/v1/15840409/cited_by?page=2